Reactivation of telomerase in cancer

SC Akincilar, B Unal, V Tergaonkar - Cellular and Molecular Life Sciences, 2016 - Springer
Activation of telomerase is a critical step in the development of about 85% of human
cancers. Levels of Tert, which encodes the reverse transcriptase subunit of telomerase, are …

Bladder cancer: epidemiology, diagnosis, and management

CL Pashos, MF Botteman, BL Laskin… - Cancer …, 2002 - Wiley Online Library
purpose: The purpose of this article is to present an overview of the epidemiology diagnosis,
and management of bladder cancer, with a focus on the early stage of this disease …

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

NV Chandrasekharan, H Dai… - Proceedings of the …, 2002 - National Acad Sciences
Two cyclooxygenase isozymes, COX-1 and-2, are known to catalyze the rate-limiting step of
prostaglandin synthesis and are the targets of nonsteroidal antiinflammatory drugs. Here we …

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

PS Rachakonda, I Hosen… - Proceedings of the …, 2013 - National Acad Sciences
The telomerase reverse transcriptase (TERT) promoter, an important element of telomerase
expression, has emerged as a target of cancer-specific mutations. Originally described in …

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

JM Jonasson, R Ljung, M Talbäck, B Haglund… - Diabetologia, 2009 - Springer
Aims/hypothesis In the light of a report suggesting that insulin glargine may increase cancer
occurrence, the EASD asked us to perform this study. Methods We followed 114,841 …

Polymorphisms in DNA repair and metabolic genes in bladder cancer

S Sanyal, F Festa, S Sakano, Z Zhang… - …, 2004 - academic.oup.com
We investigated the association of urinary bladder cancer with genetic polymorphisms in the
xeroderma pigmentosum complementation group C (XPC), group D (XPD) and group G …

Population-based case–control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk

MN Lai, SM Wang, PC Chen, YY Chen… - Journal of the National …, 2010 - academic.oup.com
Abstract Background Consumption of Chinese herbs that contain aristolochic acid (eg, Mu
Tong) has been associated with an increased risk of urinary tract cancer. Methods We …

The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain …

S Amini, F Fathi, J Mobalegi… - Anatomy & cell …, 2014 - synapse.koreamed.org
Uncontrolled self-renewal plays a direct function in the progression of different types of
carcinomas. The same molecular pathway that manages self-renewal in normal stem cells …

Evaluation of the carcinogenicity of inorganic arsenic

SM Cohen, LL Arnold, BD Beck, AS Lewis… - Critical reviews in …, 2013 - Taylor & Francis
Inorganic arsenic (iAs) at high exposures is a human carcinogen, affecting mainly the
urinary bladder, lung and skin. We present an assessment of the mode of action (MOA) of …

Bladder cancer: translating molecular genetic insights into clinical practice

L Cheng, S Zhang, GT MacLennan, SR Williamson… - Human pathology, 2011 - Elsevier
Transitional cell (urothelial) carcinoma of the bladder is the second most common urologic
malignancy and is one of the best understood neoplasms, with relatively well-defined …